重组组织型纤溶酶原激活剂50 mg/2 h方案用于国人急性肺血栓栓塞症治疗可获更好风险效益比

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F2EBC15C.svg?ark=w1%2F20260515%2FF2EBC15C)](https://nobleid.org/work/w1/20260515/F2EBC15C)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors